01 January 1999
Low-dose aspirin and serum lipoprotein(a) concentrations in patients with EPH-gestosis
Franciszek Kokot, Christian Wanner, Violetta Ciszek, Edward FranekMed Sci Monit 1999; 5(1): CR55-57 :: ID: 505214
Abstract
Introduction: Lipoprotein(a) due to its thrombogenic properties, probably plays an important role in EPHgestosis vascular injury patients. Aspirin may influence the relationship between lp(a) and vascular pathology.Material and methods: This study assessed serum Lp(a) levels in 45 healthy pregnant women (HPW), 27 women with mild or moderate gestosis and in 30 non-pregnant women. Gestosis patients comprised 10 women treated with low-dose aspirin (0.15 g/day) during the last three months of pregnancy (Asp-EPH group) and 17 women who did not receive the drug (Non-Asp-EPH group). In EPH-gestosis subjects, Lp(a) concentrations were assessed (by means of a nephelometric immunoassay method) from blood samples withdrawn three months before delivery and at the day of the expected delivery, while in HPW only during the day of expected delivery. Results: Serum Lp(a) concentration levels at term of expected delivery were of similar magnitude in HPW, Asp-EPH and Non-Asp-EPH patients (27.3±4.4 vs. 39.8±14.1 vs. 26.3±4.6 mg/dl). Although these values exceeded those of the control group (17.7±4.4 mg/dl) the difference was statistically insignificant (all values as mean±SEM). In Asp-EPH and Non-Asp-EPH women, serum Lp(a) concentrations did not change significantly during the last three months of pregnancy (from 29.3±10.4 to 39.8±14.1 and from 36.2±5.6 to 26.3±4.6 mg/dl, respectively). Conclusions: Pregnant women with mild or moderate gestosis demonstrate serum Lp(a) levels of similar magnitude as HPW. Low-dose aspirin treatment for three months does not significantly influence serum Lp(a) concentrations in EPH-gestosis patients.
Keywords: Lp(a), EPH-gestosis
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952